ATE157356T1 - 1,3,4-oxadiazol-2(3h)-one-derivate, ihre herstellung und ihre verwendung als monoaminoxidase-hemmer - Google Patents

1,3,4-oxadiazol-2(3h)-one-derivate, ihre herstellung und ihre verwendung als monoaminoxidase-hemmer

Info

Publication number
ATE157356T1
ATE157356T1 AT94402642T AT94402642T ATE157356T1 AT E157356 T1 ATE157356 T1 AT E157356T1 AT 94402642 T AT94402642 T AT 94402642T AT 94402642 T AT94402642 T AT 94402642T AT E157356 T1 ATE157356 T1 AT E157356T1
Authority
AT
Austria
Prior art keywords
group
alkoxy
derivatives
monoamine oxidase
oxadiazole
Prior art date
Application number
AT94402642T
Other languages
English (en)
Inventor
Jean-Jacques Koenig
Samir Jegham
Frederic Puech
Philippe Burnier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE157356T1 publication Critical patent/ATE157356T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT94402642T 1993-11-26 1994-11-21 1,3,4-oxadiazol-2(3h)-one-derivate, ihre herstellung und ihre verwendung als monoaminoxidase-hemmer ATE157356T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9314151A FR2712886B1 (fr) 1993-11-26 1993-11-26 Dérivés de 1,3,4-oxadiazol-2(3H)-one, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
ATE157356T1 true ATE157356T1 (de) 1997-09-15

Family

ID=9453245

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94402642T ATE157356T1 (de) 1993-11-26 1994-11-21 1,3,4-oxadiazol-2(3h)-one-derivate, ihre herstellung und ihre verwendung als monoaminoxidase-hemmer

Country Status (24)

Country Link
US (1) US5525619A (de)
EP (1) EP0655445B1 (de)
JP (1) JPH07196636A (de)
KR (1) KR950014088A (de)
CN (1) CN1106395A (de)
AT (1) ATE157356T1 (de)
AU (1) AU679127B2 (de)
CA (1) CA2136669A1 (de)
CZ (1) CZ291794A3 (de)
DE (1) DE69405198T2 (de)
DK (1) DK0655445T3 (de)
ES (1) ES2107157T3 (de)
FI (1) FI945562L (de)
FR (1) FR2712886B1 (de)
GR (1) GR3025272T3 (de)
HU (1) HUT71111A (de)
IL (1) IL111769A (de)
NO (1) NO944513L (de)
NZ (1) NZ264991A (de)
PL (1) PL305999A1 (de)
RU (1) RU94042230A (de)
SK (1) SK143594A3 (de)
TW (1) TW284761B (de)
ZA (1) ZA949394B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763068B1 (fr) * 1997-05-06 1999-06-04 Synthelabo Derives de 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2766485B1 (fr) * 1997-07-23 2002-05-24 Synthelabo Derives de 2,4-dihydro-3h-1,2,4-triazol-3-one, leur prparation et leur application en therapeutique
JP2001039954A (ja) * 1999-05-24 2001-02-13 Tomono Agrica Co Ltd ヘテロ環誘導体
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
CN104016938B (zh) * 2014-05-28 2016-08-17 浙江工业大学 一种含苯硒基的噁二唑类化合物及其制备与应用
CN104016939B (zh) * 2014-05-28 2016-06-15 浙江工业大学 一种2-亚乙基-3-乙酰基-1,3,4-噁二唑类化合物及其制备与应用
GB201814151D0 (en) * 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631827B1 (fr) * 1988-05-27 1992-03-27 Delalande Sa Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique
JPH0366056A (ja) * 1989-08-03 1991-03-20 Matsushita Electric Ind Co Ltd 回転ヘッド装置
FR2655044B1 (fr) * 1989-11-24 1995-03-03 Delalande Sa Derives d'(hetero) arylmethyloxy-4 phenyl tetrazole et oxadiazole, leur procede de preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
TW284761B (de) 1996-09-01
RU94042230A (ru) 1996-11-20
EP0655445B1 (de) 1997-08-27
CZ291794A3 (en) 1995-07-12
HUT71111A (en) 1995-11-28
NZ264991A (en) 1995-07-26
NO944513D0 (no) 1994-11-25
FI945562A7 (fi) 1995-05-27
FR2712886A1 (fr) 1995-06-02
DE69405198T2 (de) 1998-01-29
FI945562L (fi) 1995-05-27
HU9403393D0 (en) 1995-02-28
IL111769A0 (en) 1995-01-24
AU679127B2 (en) 1997-06-19
DE69405198D1 (de) 1997-10-02
CN1106395A (zh) 1995-08-09
ES2107157T3 (es) 1997-11-16
GR3025272T3 (en) 1998-02-27
JPH07196636A (ja) 1995-08-01
KR950014088A (ko) 1995-06-15
FR2712886B1 (fr) 1996-01-05
AU7903094A (en) 1995-06-01
IL111769A (en) 1999-04-11
FI945562A0 (fi) 1994-11-25
SK143594A3 (en) 1995-06-07
EP0655445A1 (de) 1995-05-31
US5525619A (en) 1996-06-11
PL305999A1 (en) 1995-05-29
DK0655445T3 (da) 1998-03-23
NO944513L (no) 1995-05-29
CA2136669A1 (en) 1995-05-27
ZA949394B (en) 1995-09-07

Similar Documents

Publication Publication Date Title
DE122009000040I1 (de) Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
SE7909392L (sv) Nya substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner
HUP0100638A2 (hu) FP agonistákként alkalmazható aromás C16-C20-szubsztituált tetrahidroprosztaglandinok és ezeket tartalmazó gyógyszerkészítmények
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
EP0632031A4 (de)
BR8901097A (pt) Processo para a preparacao de uma composicao biocida
ATE157356T1 (de) 1,3,4-oxadiazol-2(3h)-one-derivate, ihre herstellung und ihre verwendung als monoaminoxidase-hemmer
AU541413B2 (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
ZA945337B (en) Benzospiroalkene compounds process for preparing them and pharmaceutical compositions containing them
GB9320299D0 (en) Isoxazole derivatives
DK0506434T3 (da) Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler
DK0387489T3 (da) Anvendelse af 2,2,6,6-tetramethyl-4-aminopiperidinamider som fungicider
DE60000880D1 (de) Fluorierte benzodioxan imidazolin derivate, deren herstellung und deren therapeutische verwendung
ES2101910T3 (es) Composicion para acelerar la curacion de heridas.
ES2027492A6 (es) Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables.
GR3002594T3 (en) Aromatic thioethers
IL78080A0 (en) Piperazinylmethyl-1,2,4-triazolylmethyl-carbinols,their preparation and their use as plant protecting agents
HUT42284A (en) Insecticide and acaricide compositions containing substituted furazane derivatives as active agents and process for producing these compounds
TW288960B (de)
IL84266A (en) 1-hydroxyalkyl-3-alkylxanthines and pharmaceutical compositions containing them
AU4370489A (en) The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee